...We Welcome You To The Resverlogix HUB On AGORACOM!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: … the window is closing...

 

… the window is closing in on the AGM, less than a month away now…  if   we get no news in the next three and a half weeks Mr. M. knows what the questions will be for the AGM’s Q & A where we   should   finally get some answers…  it’ll be here in no time folks… glta,   kelsee

Share
New Message
Please login to post a reply